MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ALKS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alkermes (ALKS) Ownership - Who owns Alkermes?

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2050
Web
https://www.alkermes.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
7.38B
P/E Ratio
49.20
Total Cash
511.86M
Projected Growth
N/A
Total Debt
1.58B
Revenue
1.56B
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash/Share
3.07
Total Debt/Equity
27.09
Revenue/Share
9.29 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)
Annualized Return+21%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
ALKS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ALKS
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2050
Web
https://www.alkermes.com